Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians

Author:

Rubin David T1,Hart Ailsa2,Panaccione Remo3,Armuzzi Alessandro4,Suvanto Ulla5,Deuring J Jasper6,Woolcott John7,Cappelleri Joseph C8,Steinberg Kathy9,Wingate Laura10,Schreiber Stefan11

Affiliation:

1. University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, Illinois, USA

2. IBD Unit, St. Mark’s Hospital, London, UK

3. Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada

4. IBD Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS–Università Cattolica del Sacro Cuore, Rome, Italy

5. Crohn and Colitis Association of Finland, Tampere, Finland

6. Pfizer Inc, Rotterdam, The Netherlands

7. Pfizer Inc, Collegeville, Pennsylvania, USA

8. Pfizer Inc, Groton, Connecticut, USA

9. The Harris Poll, New York, New York, USA

10. Crohn’s & Colitis Foundation, New York, New York, USA

11. Department of Internal Medicine, University Hospital Schleswig-Holstein, Kiel, Germany

Abstract

Abstract Background The Ulcerative Colitis (UC) Narrative global surveys examined patient and physician perspectives on living with UC and tried to identify gaps in optimal care. Questions explored patient-physician interactions, UC management goals, and resources for improving communication. Methods Questionnaires were conducted across 10 countries, covering aspects of UC including diagnosis, treatment, and impact on patient quality of life, in addition to standard demographic information. Descriptive statistics were calculated. Results Globally, 2100 patients and 1254 physicians were surveyed (from August 2017 to February 2018). Results showed 85% of patients were satisfied with the communication they had with their physician, including discussions relating to symptoms (86%) and medication options (81%). However, 72% of patients wished for more information and support at initial diagnosis, and 48% did not feel comfortable talking to their physician about emotional concerns. Most patients (71%) set UC management goals with their physician. Both patients (63%) and physicians (79%) wished for longer appointments. Although 84% of physicians believed patient advocacy organizations to be important in UC management, more than half (54%) never discussed them with patients. Conclusions These survey results highlight overall patient satisfaction with patient-physician communication but emphasize areas for improvement, such as patient desire to have more information earlier in their disease course. There is an unmet need for better information, materials, and support. Physicians need to consider which of the available tools and resources can help patients talk more openly, and accurately, because informed patients are more likely to engage with physicians in a shared decision-making process.

Funder

Pfizer Inc

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3